StockNews.com upgraded shares of Cabot (NYSE:CBT – Free Report) from a hold rating to a buy rating in a research note released on Thursday morning.
A number of other research firms have also issued reports on CBT. UBS Group reduced their price target on Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a research report on Monday, April 7th. Mizuho reduced their target price on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating on the stock in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Cabot has a consensus rating of “Hold” and an average price target of $93.25.
Get Our Latest Stock Analysis on CBT
Cabot Trading Up 0.1 %
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Equities research analysts anticipate that Cabot will post 7.57 EPS for the current fiscal year.
Institutional Investors Weigh In On Cabot
Several institutional investors have recently added to or reduced their stakes in CBT. MML Investors Services LLC raised its holdings in Cabot by 6.5% during the third quarter. MML Investors Services LLC now owns 6,358 shares of the specialty chemicals company’s stock worth $711,000 after purchasing an additional 389 shares in the last quarter. Public Employees Retirement System of Ohio grew its position in shares of Cabot by 170.2% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 2,351 shares of the specialty chemicals company’s stock valued at $263,000 after buying an additional 1,481 shares during the last quarter. Barclays PLC grew its position in shares of Cabot by 103.9% in the 3rd quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company’s stock valued at $12,699,000 after buying an additional 57,907 shares during the last quarter. World Investment Advisors LLC acquired a new stake in Cabot during the 3rd quarter worth $3,161,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Cabot in the third quarter valued at $1,651,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories
- Five stocks we like better than Cabot
- What is the Nasdaq? Complete Overview with History
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- Conference Calls and Individual Investors
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Following Congress Stock Trades
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.